A visual scoring system has been devised to further validate such a technique and differentiate better meningiomas from other tumors expressing SSTR-2 (breast cancer, thyroid cancer, Merkel cell carcinoma, lymphoma). This evidence concerns the gene SSTR2 and lymphoma.